MicroRNA-9 Enhanced Cisplatin Sensitivity in Nonsmall Cell Lung Cancer Cells by Regulating Eukaryotic Translation Initiation Factor 5A2

Figure 5

MiR-9 enhances NSCLC cell sensitivity to cisplatin by inhibiting eIF5A2 expression. (a–c) Western blot showing eIF5A2 expression after siRNA transfection. (d–f) CCK-8 measurement of cisplatin sensitivity following siRNA transfection with miR-9 mimic or inhibitor.

(a)

(b)

(c)

(d)

(e)

(f)